Trifluridine and Tipiracil Hydrochloride Tablets, Bevacizumab and Sintilimab With/without Involved Lesions Irradiation As 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer: a Phase 2, Double Cohort Clinical Trial
Latest Information Update: 14 Jan 2025
Price :
$35 *
At a glance
- Drugs Tipiracil (Primary) ; Tipiracil/trifluridine (Primary) ; Trifluridine (Primary) ; Bevacizumab; Sindilizumab
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 14 Jan 2025 New trial record